These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 122165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon.
    Martin-Malo A, Velasco F, Rojas R, Castillo D, Rodriguez M, Torres A, Aljama P.
    Kidney Int Suppl; 1993 Jun; 41():S213-6. PubMed ID: 8320924
    [Abstract] [Full Text] [Related]

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 11. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2007 Nov; 119(4):475-80. PubMed ID: 16828495
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND, Gonzales EC, Wang J, Said S.
    Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
    [Abstract] [Full Text] [Related]

  • 18. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH, Glas-Greenwalt P, Kant KS, Allen CM, Hayes S, Pollak VE.
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [Abstract] [Full Text] [Related]

  • 19. [Activation of fibrynolysis in children with chronic B or C hepatitis].
    Michalska K, Szaflarska-Popławska A, Dymek G, Kotschy M.
    Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolytic abnormalities following liver transplantation in patients with fulminant hepatic failure.
    Pernambuco JR, Langley PG, Hughes RD, Izumi S, Williams R.
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):155-9. PubMed ID: 7536112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.